Are Kidney Stones Disrupting Your Life?

Join Our Clinical Trial for a New Treatment Option

As many as 1 in 11 Americans will face the discomfort of kidney stones at some point in their lives. These stones can cause intense pain, nausea, and urinary issues. If you or a loved one is struggling with this condition, we invite you to learn more about a promising new study and treatment option.

Nearby Participating Center

University of Virginia
Charlottesville, VA
(434) 924-6869
AMS7NN@uvahealth.org

ELS Clinical Trial for Kidney Stones

Avvio Medical is conducting a clinical trial for the Enhanced Lithotripsy System (ELS), an innovative approach to treating kidney stones. ELS uses low-pressure ultrasound and tiny microbubbles to break kidney stones into small fragments, allowing you to pass them during or after the procedure with less or no discomfort. This investigational device is being developed under an FDA Investigational Device Exemption, aiming to offer smoother and less painful stone passage.

Minimally Invasive Treatment

ELS uses ultrasound energy through the skin, eliminating the need for more invasive methods.

Less Painful Stone Passage

By breaking stones into smaller fragments, ELS may reduce or eliminate the discomfort typically felt when passing stones.

Same-Day Return Home

The procedure is outpatient, allowing you to go home the same day.

Precise and Targeted Therapy

The system uses microbubbles that release targeted energy near the stone to break it down.

What to Expect

During the Procedure

A small catheter will be inserted into your urethra to place tiny microbubbles near the stone. An external ultrasound treatment head will be positioned against your skin near the ureter to actuate the microbubbles and break down the stone.

Quick & Convenient

The ELS procedure takes approximately one hour and can be performed in a doctor’s office. Your doctor will discuss various pain-management options.

After the Procedure

You can return home the same day. Your doctor will check in on you after two weeks via a phone call. You will need to return 30 days post-procedure for a blood test and a CT scan. Additional follow-ups may be scheduled as needed.

Watch animation for more details

Why Participate in This Study?

By joining this clinical trial, you contribute to potentially bringing a new, effective treatment to the market that could help numerous patients. Participants receive comprehensive care and are closely monitored for their safety throughout the process.

Your decision to participate is voluntary, and your doctor will thoroughly explain the procedure, potential risks, and benefits. We thank you for considering joining us in this vital clinical trial to make kidney stone treatment more efficient and less painful.

Contact Your Doctor Today

Take the first step towards relief and innovation in kidney stone treatment. Contact a participating center and see if you may be eligible to be enrolled in the ELS clinical study.

Participating Centers

LocationCity, StatePhoneEmailID
AZ State Urological Research InstituteChandler, AZ(602) 842-5305dbaldonado@asuri.netASURI211
Dr. Mohamed BidairSan Diego, CA(619) 287-6000 or (619) 299-9530SDST213
University of MiamiMiami, FL(305) 243-3593ecortizas@med.miami.eduUMH229
Georgia UrologyAtlanta, GA(404) 943-9654researchteam@gaurology.comGAU234
Comprehensive Urologic CareLake Barrington, IL(847) 382-5080CUC204
Minnesota Urology Bloomington, MN(651) 999-7032eogbu@mnurology.comMNU233
Dr. Rajit Jain, Unv. of RochesterRochester, NY(585) 275-0126urmcurologyclinicalresearch@urmc.rochester.eduURMC231
Dr. Scott WienerSyracuse, NY(585) 275-2838SUNY206
Urology of San AntonioSan Antonio, TX(210) 617-4116USA218
University of VirginiaCharlottesville, VA(434) 924-6869AMS7NN@uvahealth.orgUVA210
University of Virginia Community HealthCulpeper, VA(434) 924-6869ams7nn@uvahealth.orgUVACH214
Urology of VirginiaVirginia Beach, VA(757) 452-3463JCsenar@urologyofva.netUov202
Arkansas UrologyLittle Rock, AR(501) 830-8050AURC225

CAUTION – Investigational device. Limited by Federal (or United States) law to investigational use. Avvio Medical, Inc. does not currently offer medical devices for sale or distribution and the company’s technology has not received market clearance status by the U.S. FDA or any other country’s regulatory authority.
MKT-0022